Sandoz
Also: Sandoz' digital therapeutics marketing steps out; Digital weight management tool Naturally Slim picks up new CFO.
The industry is better off viewing the the floundering deals between Onduo and Sanofi, Proteus and Otsuka, and Pear and Sandoz as a learning opportunity.
The pharma's Sandoz division will be handing commercialization of reSET, reSET-O and future therapies back to Pear over the course of a transition period.
Digital therapeutic stakeholders came together at this week's DTx East conference to discuss the state of digital health investment, developing successful business models, the need for robust data and more.
The startup was also recently awarded funding from EIT Health and Vinnova, the Swedish innovation agency.